Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2221 AL 2235

Glutathione and Related Molecules in Parkinsonism

Asanuma M, Miyazaki I.

Int J Mol Sci. 2021 Aug 13;22(16):8689. doi: 10.3390/ijms22168689.

Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons

Sini P, Dang TBC, Fais M, Galioto M, Padedda BM, Lugliè A, Iaccarino C, Crosio C.

Int J Mol Sci. 2021 Aug 13;22(16):8726. doi: 10.3390/ijms22168726.

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer's and Parkinson's Diseases

Jagaran K, Singh M.

Int J Mol Sci. 2021 Aug 23;22(16):9082. doi: 10.3390/ijms22169082.

GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways

Demuro S, Di Martino RMC, Ortega JA, Cavalli A.

Int J Mol Sci. 2021 Aug 23;22(16):9098. doi: 10.3390/ijms22169098.

Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review

Wang S, Ma J, Zeng Y, Zhou G, Wang Y, Zhou W, Sun X, Wu M.

Drug Des Devel Ther. 2021 Aug 20;15:3619-3641. doi: 10.2147/DDDT.S310686. eCollection 2021.

Editorial: Brain Insulin Resistance in Neurodevelopmental and Neurodegenerative Disorders: Mind the Gap!

Dierssen M, Barone E.

Front Neurosci. 2021 Aug 10;15:730378. doi: 10.3389/fnins.2021.730378. eCollection 2021.

Gastro-intestinal dysfunctions in Parkinson's disease (Review)

Ivan IF, Irincu VL, Diaconu Ș, Falup-Pecurariu O, Ciopleiaș B, Falup-Pecurariu C.

Exp Ther Med. 2021 Oct;22(4):1083. doi: 10.3892/etm.2021.10517. Epub 2021 Jul 29.

Dynamic control of mitochondria-associated membranes by kinases and phosphatases in health and disease

Pichla M, Sneyers F, Stopa KB, Bultynck G, Kerkhofs M.

Cell Mol Life Sci. 2021 Oct;78(19-20):6541-6556. doi: 10.1007/s00018-021-03920-9. Epub 2021 Aug 27.

Zonisamide in Parkinson's disease: a current update

Goel A, Sugumaran R, Narayan SK.

Neurol Sci. 2021 Oct;42(10):4123-4129. doi: 10.1007/s10072-021-05550-2. Epub 2021 Aug 27.

The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders

Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P.

Pharmacol Res. 2021 Oct;172:105840. doi: 10.1016/j.phrs.2021.105840. Epub 2021 Aug 24.

In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)

Costa CP, Barreiro S, Moreira JN, Silva R, Almeida H, Sousa Lobo JM, Silva AC.

Pharmaceuticals (Basel). 2021 Jul 23;14(8):711. doi: 10.3390/ph14080711.

Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update

Prasad EM, Hung SY.

Pharmaceuticals (Basel). 2021 Jul 25;14(8):717. doi: 10.3390/ph14080717.

Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease

Holanda VAD, Didonet JJ, Costa MBB, do Nascimento Rangel AH, da Silva ED Jr, Gavioli EC.

Pharmaceuticals (Basel). 2021 Aug 6;14(8):775. doi: 10.3390/ph14080775.

Aberrant Neurogliovascular Unit Dynamics in Cerebral Small Vessel Disease: A Rheological Clue to Vascular Parkinsonism

Che Mohd Nassir CMN, Damodaran T, Yusof SR, Norazit A, Chilla G, Huen I, K N BP, Mohamed Ibrahim N, Mustapha M.

Pharmaceutics. 2021 Aug 5;13(8):1207. doi: 10.3390/pharmaceutics13081207.

Cueing brain rhythms in Parkinson's disease

Albanese A.

Clin Neurophysiol. 2021 Oct;132(10):2675-2676. doi: 10.1016/j.clinph.2021.08.001. Epub 2021 Aug 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias